The Latest Breaking News on Pharma

On a day when the biggest news story for most Indian newspapers was India’s almost miraculous win in their match against Pakistan in Melbourne in the ongoing T20 World Cup, one paper decided to make a non-sport and non-political story its page 1 lead.

The company launched its lead drug Accrufer in the US last year

Africa's top public health body said on Thursday that the Ebola outbreak in Uganda was "not getting out of hand" and that it was still under control, despite an increase in cases that have spread to the capital Kampala.

The FDA delayed the delivery of 1 million vaccine doses, and many high-risk Americans were turned away from health clinics that had run out of vaccines.

The SA Network of Drug and Alcohol Services says the survey inaccurately represents the state's biggest problems.

A surge in cases of a common respiratory virus is filling up pediatric hospital beds around the U.S. The early and swift arrival of respiratory syncytial virus, or RSV, is stretching the limits of an already exhausted health care system. Layer on COVID and the flu, and you’ve got the…

WASHINGTON — The Food and Drug Administration on Wednesday postponed a critical advisory meeting on an application for the nation’s first over-the-counter birth control pill, citing the need “to review new information.”

LOS ANGELES — Evidence is continuing to mount that monkeypox vaccinations and treatments are protecting against further spread of the virus, according to Los Angeles County’s public health director.

Six schoolchildren in Uganda’s capital have tested positive for Ebola

Leading drug maker Amgen (AMGN) delivered impressive second-quarter results. The company is well-positioned for solid long-term growth, driven by its diversified and growing product portfolio, rising demand from a rapidly aging population, and continued advancements in science and technology. Given its high profitability, attractive dividends, and bright growth prospects, we…

It’s been over a week since public health activists Dinesh Thakur and T Prashant Reddy received an ominous notice from India’s Central Drugs Standard Control Organisation, warning them to stop “maligning the image of the institution and the nation at large”.